Tech & Innovation

JPM Healthcare Conference Highlights Innovations and Challenges Ahead
Tech & Innovation JPM Healthcare Conference Highlights Innovations and Challenges Ahead

The J.P. Morgan (JPM) Healthcare Conference marks the beginning of a new year for the healthcare industry, typically setting the tone for upcoming trends and innovations. Held annually at the Westin St. Francis in San Francisco, this prestigious event attracts a diverse group of stakeholders,

NEC and Biomy Partner to Advance AI-Driven Precision Pathology
Tech & Innovation NEC and Biomy Partner to Advance AI-Driven Precision Pathology

NEC Corporation and Biomy, Inc. have announced a groundbreaking partnership aimed at revolutionizing digital pathology through the integration of artificial intelligence (AI) and deep learning (DL). This collaboration, formalized in a recent Memorandum of Understanding (MoU), seeks to enhance

Can GPT-4 Revolutionize Diabetes Management with CGM Data Insights?
Tech & Innovation Can GPT-4 Revolutionize Diabetes Management with CGM Data Insights?

The potential application of GPT-4, a large language model (LLM), in simplifying diabetes management by accurately interpreting continuous glucose monitoring (CGM) data and generating actionable insights is a promising development in healthcare. Researchers have been exploring innovative ways to

AI Tool SCORPIO Predicts Cancer Treatment Responses Using Blood Tests
Tech & Innovation AI Tool SCORPIO Predicts Cancer Treatment Responses Using Blood Tests

Imagine a world where cancer patients could receive personalized treatment precisely tailored to their unique biological makeup, drastically improving their chances of success. This once-idealistic vision is now becoming a reality with the advent of SCORPIO, an innovative AI-driven tool developed

Can AI Predict Autoimmune Disease Progression with Greater Accuracy?
Tech & Innovation Can AI Predict Autoimmune Disease Progression with Greater Accuracy?

Autoimmune diseases occur when the immune system erroneously targets the body's own cells and tissues. These diseases usually present a preclinical stage with mild symptoms or specific antibodies detectable in blood tests before the disease fully manifests. However, in some cases, these symptoms

Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD
Tech & Innovation Insilico Medicine's AI-Driven Drug ISM5411 Shows Promise for Treating IBD

Insilico Medicine, a clinical-stage company leveraging generative artificial intelligence (AI) for drug discovery and development, has announced promising results for its novel drug, ISM5411, aimed at treating Inflammatory Bowel Disease (IBD). This gut-restricted and PHD-specific inhibitor was

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later